Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in QTTB — Q32 Bio Inc.

CIK 1107261 HOUSTON, TX
Back to QTTB Full portfolio

Position in QTTB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$440,969
+$359,994 QoQ
Shares Held
34,613
+174.4% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 71 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QTTB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. QTTB ranks #43 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in QTTB

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $440,969 34,613
2026-03-31 $80,975 12,613